Medical device company Procyrion, Inc. announced on Monday that it has named Lucas Buchanan as a new director.
Buchanan, a MedTech executive and experienced board member, is presently the chief operating officer and chief financial officer at Silk Road Medical. He has served in investment and commercial roles at The Vertical Group, Impax Laboratories, Medtronic and Ernst & Young. Currently, he serves on the board of directors for Endologix and as a strategic advisory board member of CRG LP.
Gary F Burbach, chair of the board of directors, Procyrion, said, 'We are thrilled to have an accomplished leader like Lucas join the Procyrion Board. Lucas' deep industry experience will be an important asset to the board and company as we work together to make the groundbreaking Aortix therapy available for patients with acute decompensated heart failure.'
Breg names new chief executive officer and chief financial officer
Magellan Health launches Teen Mental Wellbeing app powered by BeMe
Azenta names new president and CEO
PHC announces launch of LiCellMo live cell metabolic analyzer targeting CGT advancements
Heron Therapeutics names new chief business officer
Expanse Medical names new chief executive officer and FlowPhysix board member
ClariMed opens new Leeds, UK office
Nightingale Health gains UKCA certification and expands with new laboratory
Talphera enrols first subject in NEPHRO CRRT study
China Pharma Holdings anticipates launch of Dry Eye Disease Therapeutic Device in early 2025
SOPHiA DDM Platform achieves IVDR certification, enhancing diagnostic precision
Medtronic reports FDA approval of Simplera CGM; partners with Abbott